Skip to Content

187 (Carbidopa and levodopa (orally disintegrating) 25 mg / 100 mg)

Pill imprint 187 has been identified as Carbidopa and levodopa (orally disintegrating) 25 mg / 100 mg.

Carbidopa/levodopa is used in the treatment of restless legs syndrome; parkinson's disease; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 25 mg / 100 mg is not a controlled substance under the Controlled Substance Act (CSA).

Carbidopa and levodopa (orally disintegrating) 25 mg / 100 mg 187
Discount Card Promo
Carbidopa and levodopa (orally disintegrating)
Imprint:
187
Strength:
25 mg / 100 mg
Color:
Yellow
Shape:
Round
Availability:
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Sun Pharmaceuticals
National Drug Code (NDC):
62756-0187
Inactive Ingredients:
povidone
mannitol
calcium silicate
crospovidone
magnesium silicate
magnesium stearate
aspartame
silicon dioxide colloidal
microcrystalline cellulose
D&C Yellow No. 10
FD&C Yellow No. 6
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
47335-0187 Sun Pharmaceutical Industries Inc.

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide